Automating Infusion Therapy Prior Authorizations with Magellan Healthcare
Navigating the complexities of prior authorization for Infusion Therapy with Magellan Healthcare requires a strategic approach to utilization management and documentation submission. Klivira provides a robust solution to automate this critical workflow.
Revenue cycle directors and prior authorization coordinators face significant challenges when managing Infusion Therapy requests through Magellan Healthcare, a Centene-owned utilization management entity. The intricate RBM (Rule-Based Management) routing and stringent site-of-service review processes demand precise documentation and efficient workflow management to mitigate denials and ensure timely patient access to care.
Understanding Magellan Healthcare's UM for Infusion Therapy
Magellan Healthcare's utilization management protocols for infusion therapy are characterized by a focus on medical necessity, appropriate site of service (home, office, HOPD), and evidence-based clinical criteria. Their RBM system often routes requests based on drug, diagnosis, and patient history, necessitating a proactive approach to submitting comprehensive clinical data.
Critical Documentation for Magellan Infusion PA
- Detailed clinical notes supporting the diagnosis and medical necessity of the infusion therapy.
- Treatment plan, including drug name, dosage, frequency, and duration.
- Relevant laboratory results (e.g., tumor markers, inflammatory markers, genetic testing).
- Imaging studies (e.g., MRI, CT scans) if applicable to diagnosis or treatment monitoring.
- Documentation of failed prior therapies or contraindications to alternative treatments.
- Site-of-service justification, especially for home or outpatient hospital settings, addressing clinical stability and safety.
Common Denial Themes for Infusion Therapy with Magellan
Denials from Magellan Healthcare for infusion therapy often stem from insufficient clinical documentation, lack of medical necessity per their guidelines, or inappropriate site-of-service designation. Specific challenges include inadequate justification for a higher-cost site of care, missing prior treatment history, or failure to meet RBM-driven clinical criteria, leading to delays and potential appeals.
Navigating Peer-to-Peer Review for Infusion Therapy
When a prior authorization request for infusion therapy is denied by Magellan Healthcare, a peer-to-peer (P2P) review may be necessary. Preparing for these discussions requires a thorough understanding of the specific denial reason, comprehensive patient clinical history, and clear articulation of the medical rationale for the requested therapy and site of service. Our platform helps consolidate this information for efficient P2P engagement.
Automating Magellan Infusion Therapy Workflows with Klivira
Klivira integrates directly with EMRs and payer portals, including those utilized by Magellan Healthcare, to automate the submission and tracking of infusion therapy prior authorizations. Our solution leverages SMART on FHIR and X12 278 standards to streamline data exchange, reducing manual effort and improving the accuracy of submissions for complex RBM and site-of-service reviews.
Frequently asked questions
How does Klivira handle Magellan's site-of-service review for infusion therapy?
Klivira's platform is configured to identify and prompt for the specific clinical justifications required by Magellan Healthcare for various infusion therapy sites of service. It helps ensure that necessary documentation, such as patient stability criteria or lack of suitable home care, is included in the initial submission, reducing back-and-forth and potential denials.
Can Klivira integrate with my EMR to pull infusion therapy documentation for Magellan PAs?
Yes, Klivira offers robust integration capabilities with major EMR systems using SMART on FHIR and other secure APIs. This allows for automated extraction of relevant clinical notes, lab results, and other documentation required for Infusion Therapy prior authorizations with Magellan Healthcare, minimizing manual data entry.
What is the typical turnaround time for an Infusion Therapy PA with Magellan Healthcare using automation?
While Klivira significantly accelerates the preparation and submission phases of prior authorizations, the final turnaround time is dependent on Magellan Healthcare's processing. Our automation focuses on ensuring a complete and accurate submission, which often reduces the need for additional information requests and can expedite the overall review process.
Does Klivira support the appeals process for denied Infusion Therapy PAs from Magellan?
Klivira streamlines the appeals process by centralizing all submitted documentation and denial reasons. While the appeal itself requires clinical input, our platform provides the necessary framework to quickly compile and resubmit information, supporting your team in advocating for appropriate patient care.
Related coverage
Ready to automate this workflow?
See how Klivira automates prior authorizations for your team.
Request a demo